Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Genetic variation in toll-like receptors and retinoic acid-inducible gene I and outcome of hepatitis C virus infection: a candidate gene association study.

Clausen LN, Ladelund S, Weis N, Bukh J, Benfield T.

J Viral Hepat. 2014 Aug;21(8):578-84. doi: 10.1111/jvh.12188. Epub 2013 Nov 13.

PMID:
24224717
2.

SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4.

Youssef SS, Hamdy NM.

Arch Virol. 2017 Nov;162(11):3347-3354. doi: 10.1007/s00705-017-3498-7. Epub 2017 Jul 31.

PMID:
28762092
3.

Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection.

Fischer J, Weber ANR, Böhm S, Dickhöfer S, El Maadidi S, Deichsel D, Knop V, Klinker H, Möller B, Rasenack J, Wang L, Sharma M, Hinrichsen H, Spengler U, Buggisch P, Sarrazin C, Pawlita M, Waterboer T, Wiese M, Probst-Müller E, Malinverni R, Bochud PY, Gardiner C, O'Farrelly C, Berg T.

Gut. 2017 Oct;66(10):1829-1837. doi: 10.1136/gutjnl-2015-310239. Epub 2016 Apr 21.

PMID:
27196570
4.

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.

Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, Rodrigues SD, Li S, Hansen JA, Zhao LP, Aderem A, Boeckh M.

N Engl J Med. 2008 Oct 23;359(17):1766-77. doi: 10.1056/NEJMoa0802629.

5.

Sex-specific association between X-linked Toll-like receptor 7 with the outcomes of hepatitis C virus infection.

Yue M, Feng L, Tang SD, Wang JJ, Xue XX, Ding WL, Zhang Y, Deng XZ.

Gene. 2014 Sep 15;548(2):244-50. doi: 10.1016/j.gene.2014.07.040. Epub 2014 Jul 15.

PMID:
25034660
6.

Association of interleukin-18 gene polymorphisms with the outcomes of hepatitis C virus infection in high-risk Chinese Han population.

Yue M, Wang JJ, Tang SD, Feng L, Zhang Y, Liu Y, Wang J, Deng XZ, Xu K, Zhang J.

Immunol Lett. 2013 Jul-Aug;154(1-2):54-60. doi: 10.1016/j.imlet.2013.08.007. Epub 2013 Aug 23.

PMID:
23978570
7.
8.

Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus.

Hoffmann FS, Schmidt A, Dittmann Chevillotte M, Wisskirchen C, Hellmuth J, Willms S, Gilmore RH, Glas J, Folwaczny M, Müller T, Berg T, Spengler U, Fitzmaurice K, Kelleher D, Reisch N, Rice CM, Endres S, Rothenfusser S.

Hepatology. 2015 Feb;61(2):460-70. doi: 10.1002/hep.27344. Epub 2015 Jan 5.

9.

Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.

Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, Matsuura Y, Yamaguchi K, Mizuochi T.

J Innate Immun. 2010;2(6):607-17. doi: 10.1159/000317690. Epub 2010 Aug 17.

10.

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.

Potter C, Cordell HJ, Barton A, Daly AK, Hyrich KL, Mann DA, Morgan AW, Wilson AG; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Isaacs JD.

Ann Rheum Dis. 2010 Jul;69(7):1315-20. doi: 10.1136/ard.2009.117309. Epub 2010 May 6.

PMID:
20448286
11.

Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection.

Clausen LN, Weis N, Ladelund S, Madsen L, Lunding S, Tarp B, Christensen PB, Krarup HB, Møller A, Gerstoft J, Clausen MR, Benfield T; DANHEP group.

Int J Mol Sci. 2015 Feb 2;16(2):3213-25. doi: 10.3390/ijms16023213.

12.

Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus.

Hammond T, Lee S, Watson MW, Flexman JP, Cheng W, Fernandez S, Price P.

Cell Immunol. 2010;264(2):150-5. doi: 10.1016/j.cellimm.2010.06.001. Epub 2010 Jun 8.

PMID:
20579979
13.

Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.

Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL.

J Infect Dis. 2010 May 1;201(9):1371-80. doi: 10.1086/651606.

14.

Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study.

Guzmán-Fulgencio M, Berenguer J, Jiménez-Sousa MA, Pineda-Tenor D, Aldámiz-Echevarria T, García-Broncano P, Carrero A, García-Álvarez M, Tejerina F, Diez C, Vazquez-Morón S, Resino S.

J Transl Med. 2015 Jun 30;13:206. doi: 10.1186/s12967-015-0577-y.

15.

Toll-like receptor 7 variations are associated with the susceptibility to HCV infection among Chinese females.

Yue M, Gao CF, Wang JJ, Wang CJ, Feng L, Wang J, Yu RB, Peng ZH, Xue XX, Cai L, Fan NJ, Zhang Y, Deng XZ.

Infect Genet Evol. 2014 Oct;27:264-70. doi: 10.1016/j.meegid.2014.07.034. Epub 2014 Aug 7.

PMID:
25108054
16.

Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users.

Sugden PB, Cameron B, Luciani F, Lloyd AR; HITS Investigators.

J Viral Hepat. 2014 Aug;21(8):e65-73. doi: 10.1111/jvh.12232. Epub 2014 Feb 26.

PMID:
24612442
17.

HAVCR1 gene haplotypes and infection by different viral hepatitis C virus genotypes.

Abad-Molina C, Garcia-Lozano JR, Montes-Cano MA, Torres-Cornejo A, Torrecillas F, Aguilar-Reina J, Romero-Gómez M, López-Cortés LF, Núñez-Roldan A, González-Escribano MF.

Clin Vaccine Immunol. 2012 Feb;19(2):223-7. doi: 10.1128/CVI.05305-11. Epub 2011 Dec 21.

18.

Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination.

Kimman TG, Banus S, Reijmerink N, Reimerink J, Stelma FF, Koppelman GH, Thijs C, Postma DS, Kerkhof M.

PLoS One. 2008;3(11):e3665. doi: 10.1371/journal.pone.0003665. Epub 2008 Nov 6.

19.

Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population.

Cui Q, Zhang YX, Su J, Chen X, Ding K, Lei N, Liu Y, Li J, Zhang Y, Yu RB.

Infect Genet Evol. 2011 Oct;11(7):1682-9. doi: 10.1016/j.meegid.2011.06.016. Epub 2011 Jun 30.

PMID:
21742059
20.

Endosomal toll-like receptor gene polymorphisms and susceptibility to HIV and HCV co-infection - Differential influence in individuals with distinct ethnic background.

Valverde-Villegas JM, Dos Santos BP, de Medeiros RM, Mattevi VS, Lazzaretti RK, Sprinz E, Kuhmmer R, Chies JA.

Hum Immunol. 2017 Feb;78(2):221-226. doi: 10.1016/j.humimm.2017.01.001. Epub 2017 Jan 4.

PMID:
28062211

Supplemental Content

Support Center